Please assess the completion status of the following clinical trial:

Trial Title: Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (≥18 years)~* Signed informed consent~* Subjects affiliated with an appropriate social security system~* Body mass index above 30 kg/m2 and~* Pathological waist circumference according to criteria of NCEP ATPIII (men : 94 cm and women : 80 cm)~Exclusion Criteria:~* Pregnancy~* Sepsis~* Recent surgery (less than 30 days)~* Any recent severe acute conditions requiring hospitalisation (less than 30 days)~* Recent use (\< 7 days) of oral steroids, inhaled, dermal, collyrium, infiltration~* Long-term oral corticosteroids~* Nicotinic substitute or per os licorice in 2 weeks before the inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Salivary cortisol (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).